Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Ijichi

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Oncoimmunology|July 4, 2012
Inhibition of CXCLs/CXCR2 axis in the tumor microenvironment might be a potent therapeutics for pancreatic cancerHideaki Ijichi
Cancers|May 13, 2023
Significance of Tumor Microenvironment for Regulating Pancreatic CancerHideaki Ijichi
World Journal of Clinical Oncology|May 26, 2011
Genetically-engineered mouse models for pancreatic cancer: Advances and current limitationsHideaki Ijichi
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[TGF-beta signaling pathway in pancreatic cancer cells]Hideaki Ijichi
Cancers|October 14, 2022
Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the DynamicsHideaki Ijichi
Cancers|September 23, 2022
The Role of the Microbiome in Pancreatic CancerKoji Miyabayashi, Hideaki Ijichi, Mitsuhiro Fujishiro
Cancers|September 9, 2022
The Role of Neural Signaling in the Pancreatic Cancer MicroenvironmentRyota Takahashi, Hideaki Ijichi, Mitsuhiro Fujishiro
Nature Communications|September 27, 2016
Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1Takahiro Kishikawa, Motoyuki Otsuka, Takeshi Yoshikawa, et al.
Pain Research & Management|June 22, 2026
High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Through Microenvironmental AlterationTomoya Kuramochi, Tomoaki Itaya, Makoto Sano, et al.
Molecular Therapy Oncolytics|January 9, 2023
Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitorsTomoharu Yamada, Ryosuke Tateishi, Miwako Iwai, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Oncoimmunology|July 4, 2012
Inhibition of CXCLs/CXCR2 axis in the tumor microenvironment might be a potent therapeutics for pancreatic cancerHideaki Ijichi
Cancers|May 13, 2023
Significance of Tumor Microenvironment for Regulating Pancreatic CancerHideaki Ijichi
World Journal of Clinical Oncology|May 26, 2011
Genetically-engineered mouse models for pancreatic cancer: Advances and current limitationsHideaki Ijichi
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[TGF-beta signaling pathway in pancreatic cancer cells]Hideaki Ijichi
Cancers|October 14, 2022
Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the DynamicsHideaki Ijichi
Cancers|September 23, 2022
The Role of the Microbiome in Pancreatic CancerKoji Miyabayashi, Hideaki Ijichi, Mitsuhiro Fujishiro
Cancers|September 9, 2022
The Role of Neural Signaling in the Pancreatic Cancer MicroenvironmentRyota Takahashi, Hideaki Ijichi, Mitsuhiro Fujishiro
Nature Communications|September 27, 2016
Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1Takahiro Kishikawa, Motoyuki Otsuka, Takeshi Yoshikawa, et al.
Pain Research & Management|June 22, 2026
High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Through Microenvironmental AlterationTomoya Kuramochi, Tomoaki Itaya, Makoto Sano, et al.
Molecular Therapy Oncolytics|January 9, 2023
Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitorsTomoharu Yamada, Ryosuke Tateishi, Miwako Iwai, et al.
Pageof 12